PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis- 5 Year Results from an Open Label Extension Study
Abstract
Authors
V. Strand O. Purcaru R. Van vollenhoven E. Choy R. Fleischmann